Product Price: Ask Latest Price
|Minimum Order Quantity||1 Unit|
Zydus group has launched SoviHep, which will provide succour to more than 10 million patients who suffer in India. The therapy will be MARKETED by the speciality division of the group, Zydus Heptiza. Zydus and Sciences had signed a non-exclusive licensing agreement which will allow the manufacture of sofosbuvir and the fixed-dose combination of ledipasvir/ sofosbuvir for distribution in 91 countries including India.
Warning: The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.
Note: Sovihep is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Delivery Time: 10-12 days